These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 770363)

  • 1. Application of the neuroleptic pimozide (ORAP-R 6238) for tranquilizer indications in a controlled study.
    Pöldinger W
    Int Pharmacopsychiatry; 1976; 11(1):16-24. PubMed ID: 770363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative double-blind trial of pimozide in stress-induced psychic and functional disorders.
    Reyntjens AM; Van Mierlo FP
    Curr Med Res Opin; 1972; 1(2):116-22. PubMed ID: 4589018
    [No Abstract]   [Full Text] [Related]  

  • 3. A double blind study of pimozide versus chlordiazepoxide in anxiety neuroses.
    Doongaji DR; Sheth AS; Ramesh SP; Jeste DV; Ravindranath P
    Acta Psychiatr Belg; 1976; 76(4):632-43. PubMed ID: 798468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pimozide (orap, R 6238) in residual schizophrenia. A clinical evaluation with long-term double-blind follow-up.
    Denijs EL; Vereecken JL
    Psychiatr Neurol Neurochir; 1973; 76(1):47-59. PubMed ID: 4699105
    [No Abstract]   [Full Text] [Related]  

  • 5. The observer interaction variable in evaluation of socialising properties of pimozide (Orap).
    McInnes EJ; Walker F; Snelling E
    N Z Med J; 1978 Mar; 87(607):170-2. PubMed ID: 349428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of pimozide in clinical psychiatry: a review.
    Opler LA; Feinberg SS
    J Clin Psychiatry; 1991 May; 52(5):221-33. PubMed ID: 2033030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of a new benzodiazepine preparation, S-804, for the treatment of psychoneurotic and psychosomatic disorders by double-blind cross-over test].
    Tanaka H; Takayama I; Ookubo N; Yoshimuta S; Kono Y
    Saishin Igaku; 1970 May; 25(5):1128-36. PubMed ID: 4912179
    [No Abstract]   [Full Text] [Related]  

  • 8. Camazepam versus diazepam: a double-blind trial on psychoneurotic patients.
    Deberdt R
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):32-9. PubMed ID: 237742
    [No Abstract]   [Full Text] [Related]  

  • 9. [Betamed in the treatment of psychogenic disorders with a somatic component].
    Jellinger K
    Wien Med Wochenschr; 1983 Sep; 133(18):463-7. PubMed ID: 6359726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stress-related emotional lability syndrome. 1. Definition, psychophysiological mechanisms and a pilot experience with Orap.
    Wetzels MH
    Acta Psychiatr Belg; 1977; 77(2):267-76. PubMed ID: 906886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Halazepam and diazepam in neurotic anxiety: a double-blind study.
    Rickels K; Pereira-Organ J; Csanalosi I; Morris RJ; Rosenfeld H; Sablosky L; Schless A; Werblowsky JH
    Psychopharmacology (Berl); 1977 Apr; 52(2):129-36. PubMed ID: 18749
    [No Abstract]   [Full Text] [Related]  

  • 12. Relief of anxiety and related emotions in patients with gastrointestinal disorders. A double-blind controlled study.
    Deutsch EM
    Am J Dig Dis; 1971 Dec; 16(12):1091-4. PubMed ID: 4944409
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term tranquilizers - an alternative in medical practice (author's transl)].
    Pach J; Waniek W
    Arzneimittelforschung; 1976; 26(6):1189-90. PubMed ID: 786318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo-controlled, double-blind comparison of clobazam and diazepam in the treatment of anxiety.
    Jacobson AF; Goldstein BJ; Dominguez RA; Steinbook RM
    J Clin Psychiatry; 1983 Aug; 44(8):296-300. PubMed ID: 6135690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative evaluation of the effect of minor tranquilizers, benzodiazepine derivatives, medazepam (S-804) and diazepam on psychosomatic symptoms--estimtion of dosage ratio by the double blind method].
    Fukuda I; Kamide H; Higuchi H; Fujiwara K; Nakamura Y
    Saishin Igaku; 1971 Aug; 26(8):1564-7. PubMed ID: 4936623
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to trifluoperazine-amobarbital in outpatients with anxiety. (A double-blind, placebo-controlled study).
    Guthrie MB; Free SM
    Dis Nerv Syst; 1969 Mar; 30(3):195-200. PubMed ID: 4886703
    [No Abstract]   [Full Text] [Related]  

  • 17. Pimozide versus chlordiazepoxide in anxiety neurosis.
    Doongaji DR; Sheth AS; Apte JS; Bharucha MP; Mundra VM; Ramesh S
    Acta Psychiatr Belg; 1981; 81(4):416-23. PubMed ID: 7036658
    [No Abstract]   [Full Text] [Related]  

  • 18. Pilot evaluation of Orap (pimozide, R 6238) in child psychiatry.
    Pangalila-Ratulangi EA
    Psychiatr Neurol Neurochir; 1973; 76(1):17-27. PubMed ID: 4572950
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients.
    Gross HS
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):696-705. PubMed ID: 4210459
    [No Abstract]   [Full Text] [Related]  

  • 20. A series of multicentric pilot trials with pimozide in psychiatric practice. 3. Pimozide in the treatment of stress-induced psychic and functional disorders.
    Reyntjens AM
    Acta Psychiatr Belg; 1972 Nov; 72(6):671-6. PubMed ID: 4679635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.